Results for this period
Interim period (second quarter)1 April 2026–30 September 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
The semiconductor-related business posted lower sales and an operating loss due to continued demand adjustments and a limited number of projects. The measurement and metrology equipment business posted increases in both sales and profit due to solid performance in Japan and Asia, expense controls, and U.S. tariff refunds. The medical and healthcare equipment business posted increases in both sales and profit due to overseas demand, U.S. tariff refunds, foreign exchange movements, and appropriate sales pricing, among other factors.
No matters to report.
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026–30 September 2026 |
| Net Sales | ¥30,172 million (YoY -0.7%) |
| Operating profit | ¥2,178 million (YoY -31.0%) |
| Ordinary income | ¥2,273 million (YoY -31.7%) |
| Profit attributable to owners of the parent | ¥1,666 million (YoY -2.2%) |
| Net income per share | ¥60.84 |
| Equity ratio | End of the current fiscal period 65.6 / End of previous period 65.7 |
| Total assets | ¥76,412 million |
| Net assets | ¥50,190 million |
| Full-year earnings forecast | Net Sales ¥70,000 million (YoY +1.0%) / Operating profit ¥8,000 million (YoY -13.1%) / Ordinary income ¥8,200 million (YoY -13.4%) / Profit attributable to owners of the parent ¥5,500 million (YoY -7.1%) |
| Revision to Earnings Forecast | Net Sales Not disclosed → ¥70,000 million / Operating profit Not disclosed → ¥8,000 million / Ordinary income Not disclosed → ¥8,200 million / Profit attributable to owners of the parent Not disclosed → ¥5,500 million |
| Annual Dividend Forecast | ¥55 → ¥60 |
| Segment revenue | Semiconductor-related business ¥1,279 million (YoY -74.8%) / Measurement and metrology equipment business ¥14,925 million (YoY +10.5%) / Medical and healthcare equipment business ¥13,967 million (YoY +18.4%) |
| Segment profit | Semiconductor-related business ¥-675 million / Measurement and metrology equipment business ¥1,027 million (YoY +51.3%) / Medical and healthcare equipment business ¥2,909 million (YoY +70.5%) |
| Regional sales | Semiconductor-related business Japan ¥1,200 million / The Americas ¥40 million / Europe Not disclosed / Asia and Oceania ¥38 million / Measurement and metrology equipment business Japan ¥8,893 million / The Americas ¥2,418 million / Europe ¥368 million / Asia and Oceania ¥3,244 million / Medical and healthcare equipment business Japan ¥2,196 million / The Americas ¥6,304 million / Europe ¥5,114 million / Asia and Oceania ¥352 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of fixed assets ¥8 million / Gain on bargain purchase ¥242 million / Extraordinary loss Loss from embezzlement ¥28 million / Loss on sale of non-current assets ¥0 million / Loss on disposal of non-current assets ¥16 million |
| Disclosure regarding the going concern assumption | No matters to report. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 1 / Company name 株式会社エーディーシー / Excluded Number of companies 0 / Company name Not disclosed |
| Availability of Supplementary Financial Results Materials | Available |
| Availability of Financial Results Briefing | Yes (for institutional investors) |
| Issued Shares at Period-End | 27,845,208 |
| Treasury Shares at Period-End | 456,347 |
| Factors Behind Changes in Business Performance | The semiconductor-related business posted lower sales and an operating loss due to continued demand adjustments and a limited number of projects. The measurement and metrology equipment business posted increases in both sales and profit due to solid performance in Japan and Asia, expense controls, and U.S. tariff refunds. The medical and healthcare equipment business posted increases in both sales and profit due to overseas demand, U.S. tariff refunds, foreign exchange movements, and appropriate sales pricing, among other factors. |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the semiconductor-related business, demand adjustments continued, and the number of projects reaching the stage of revenue recognition was limited, resulting in an operating loss because fixed costs could not be absorbed. The measurement and metrology equipment business posted higher profit due to solid performance in Japan and Asia, the effects of expense controls, and U.S. tariff refunds. The medical and healthcare equipment business posted increases in both sales and profit due to overseas demand, U.S. tariff refunds, foreign exchange movements, and appropriate sales pricing, among other factors. The reason given for revising the full-year forecast was “recent business trends and other factors.”